Results 111 to 120 of about 134,100 (245)

Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature

open access: yesHaematologica, 2018
Although it is known that B-cell lymphomas occur more frequently in immunocompromised patients, thus far such an association has not been clearly established for T-cell lymphomas.
Marieke L. Nijland   +5 more
doaj   +1 more source

Sustained delivery and molecular targeting of a therapeutic monoclonal antibody to metastases in the central nervous system of mice. [PDF]

open access: yes, 2019
Approximately 15-40% of all cancers develop metastases in the central nervous system (CNS), yet few therapeutic options exist to treat them. Cancer therapies based on monoclonal antibodies are widely successful, yet have limited efficacy against CNS ...
Chen, Irvin SY   +17 more
core  

Tumor‐infiltrating B cells participate in shaping the immunosuppressive microenvironment in solid tumors

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Tumor‐infiltrating B cells (TIBs) exhibit dual roles in the tumor microenvironment (TME) of solid tumors. While they can enhance anti‐tumor immunity through antibody production and immune activation, certain subsets—such as regulatory B cells (Bregs) and immunosuppressive plasma cells—contribute to immune evasion by secreting inhibitory ...
Zhitong Li   +5 more
wiley   +1 more source

DNA methyltransferase inhibitors in hematological malignancies and solid tumors

open access: yesInternational Journal of Cancer, EarlyView.
Abstract Epigenetic modifications such as DNA methylation play a fundamental role in oncogenesis and the progression of neoplasms neoplasias. DNA methyltransferase inhibitors (DNMTi) constitute a family of therapeutic agents that impede the methylation at the 5‐position on cytosine nucleotides, thereby modulating the epigenetic regulation of tumor ...
Valentin Wenger   +3 more
wiley   +1 more source

Complete remission with ibrutinib after allogeneic stem cell transplant for central nervous system relapse of mantle cell lymphoma: A case report and literature review

open access: yesClinical Case Reports, 2019
Central nervous system (CNS)‐relapsed mantle cell lymphoma (MCL) is a rare, aggressive non‐Hodgkin lymphoma without a standard treatment. Ibrutinib has shown promising results for inducing remission in other non‐Hodgkin lymphomas and may be considered as
Jessica D. Rich   +5 more
doaj   +1 more source

Anti‐NMDA receptor autoimmune encephalitis associated with ovarian teratoma: A case series and literature review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 23-30, April 2025.
Abstract Autoimmune encephalitis is a group of disorders characterized by symptoms of dysfunction of the limbic and extra‐limbic systems that occur in association with antibodies against intracellular antigens, synapses, or proteins located on the surface of nerve cells. Anti‐NMDA (N‐methyl‐D‐aspartate) receptor encephalitis was first described in 2007
Pham Ba Nha   +6 more
wiley   +1 more source

Can Burkitt's Lymphoma and Hodgkin's Lymphoma occur in siblings simultaneously?

open access: yesThe Turkish Journal of Pediatrics, 2015
Familial clustering of Hodgkin lymphoma (HL) and increased risk of developing disease among the siblings has been reported earlier. Usually familial lymphoma in sibling pairs occurs in the pairs of either non-Hodgkin lymphoma or HL.
Meriç Kaymak Cihan   +5 more
doaj  

Optimizing Markers for Chronic Lymphocytic Leukemia Diagnosis by Flow Cytometry: Results From the Nationwide Thai Lymphoma Study Group

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
Our study proposed a practical set of customized flow cytometry markers that enhance the diagnosis of CLL by improving both sensitivity and accuracy. Moreover, these markers hold significant prognostic value. The identification of relapse‐associated markers provides critical insights to inform personalized treatment and monitoring strategies.
Ornnicha Sathitakorn   +16 more
wiley   +1 more source

Diagnostic criteria and new therapeutic options for patients diagnosed with non-Hodgkin lymphoma

open access: yesArchivo Médico de Camagüey, 2019
Background: malignant haemopathies increase their incidence and proliferation within the population, among them the lymphoproliferative syndrome occupies an important place, it is a group of disorders of clonal origin, which affects the lymphoid cells ...
Yaimé Moreno-Laguard   +5 more
doaj  

Clinical Application of Using Diffusion‐Based Wasserstein Generative Adversarial Network for Morphologic Analysis of Blood Cells

open access: yesJournal of Clinical Laboratory Analysis, EarlyView.
This study evaluated the accuracy of blood cell classification using 78,494 images across 13 cell classes, demonstrating a significant improvement with the DWGAN‐GP augmented dataset. The use of synthetic images increased the classification accuracy to 97.74%, outperforming both unbalanced data and commercial systems.
Hyun‐Young Kim   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy